Price alert —
Sign in to get a one-time email the moment A crosses your price. Free accounts included.
Sign in / create a free accountPrice chart
Loading…
Latest bar · A
Momentum reads · latest daily barGreen means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.
Financial overlay · last 12 quarters
The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.
| Quarter | Revenue | Net income | Op income | FCF | Net margin | Op margin |
|---|---|---|---|---|---|---|
| 2026-04-30 | $1.8B | $0.3B | $0.4B | $0.2B | 18.5% | 21.7% |
| 2026-01-31 | $1.8B | $0.3B | $0.4B | $0.2B | 17.0% | 19.6% |
| 2025-10-31 | $1.9B | $0.4B | $0.4B | $0.5B | 23.3% | 23.8% |
| 2025-07-31 | $1.7B | $0.3B | $0.4B | $0.3B | 19.3% | 20.7% |
| 2025-04-30 | $1.7B | $0.2B | $0.3B | $0.1B | 12.9% | 18.0% |
Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.
Compare A vs peers
Line A up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.
Add tickers to compare with A
~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.
Earnings replay · last 0 reports
How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.
No earnings history available.
Peer comparison · Healthcare
Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.
| Ticker ⇅ | Mkt cap ⇅ | P/E ⇅ | Fwd P/E ⇅ | P/S ⇅ | EV/EBITDA ⇅ | P/B ⇅ | Gross M ⇅ | Rev gr ⇅ | EPS gr ⇅ | FCF yld ⇅ |
|---|---|---|---|---|---|---|---|---|---|---|
| A ★ | $37B | 26.4 | 19.9 | 5.1 | 19.3 | 5.2 | 52.6% | 10.0% | 60.0% | 2.51% |
| LLY | $1,051B | 41.8 | 26.3 | 14.6 | 30.1 | 33.8 | 82.8% | 55.5% | 169.9% | 0.87% |
| UNH | $387B | 32.1 | 19.2 | 0.9 | 17.7 | 4.0 | 19.5% | 0.4% | 61.5% | 5.88% |
| JNJ | $609B | 29.3 | 19.7 | 6.2 | 18.4 | 7.5 | 68.1% | 6.6% | -1.0% | — |
| MRK | $315B | 36.0 | 13.2 | 4.8 | 12.1 | 6.9 | 76.7% | 4.9% | — | 4.46% |
| ABBV | $450B | 124.8 | 15.6 | 7.2 | 17.2 | -67.6 | 72.0% | 12.4% | -46.2% | 4.63% |
| PFE | $143B | 19.1 | 8.8 | 2.3 | 7.6 | 1.6 | 74.8% | 5.4% | -10.1% | 8.67% |
| TMO | $198B | 29.2 | 19.5 | 4.4 | 21.1 | 3.8 | 40.9% | 6.2% | 11.3% | 2.79% |
Auto-seeded from sector. Click any ticker to switch.
Ownership
Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.
Top institutional holders
Top-10 concentration: 42.03%
| Holder | Shares | % out |
|---|---|---|
| Blackrock Inc. | 25,902,662 | 9.17% |
| Vanguard Capital Management LLC | 18,381,030 | 6.51% |
| Vanguard Portfolio Management LLC | 14,352,682 | 5.08% |
| State Street Corporation | 12,764,632 | 4.52% |
| Massachusetts Financial Services Co. | 12,624,090 | 4.47% |
| T. Rowe Price Investment Management, | 8,992,649 | 3.18% |
| Geode Capital Management, LLC | 7,522,028 | 2.66% |
| Wellington Management Group, LLP | 7,256,433 | 2.57% |
| Deutsche Bank AG | 5,984,118 | 2.12% |
| Morgan Stanley | 4,949,129 | 1.75% |
Insider activity · 90d
1 buys / 1 sells · ratio 1.0 · Finnhub
- MCDONNELL PADRAIG F 65,842 @ $137.40
- Dolsten Mikael SELL 5,548 @ $135.42
- Buckner Michael Steven BUY 8,887
- MAY SIMON F 14,015 @ $115.62
Analyst estimates
FinnhubWhat Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.
SEC filings
The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.
| Form | Filed | Description | Action |
|---|---|---|---|
| 4 | 2026-06-29 | PRIMARY DOCUMENT | view · |
| 8-K | 2026-06-25 | 8-K | view · |
| 4 | 2026-06-05 | PRIMARY DOCUMENT | view · |
| 4 | 2026-06-02 | PRIMARY DOCUMENT | view · |
| 10-Q | 2026-06-01 | 10-Q | view · |
| 8-K | 2026-05-27 | 8-K | view · |
| 4 | 2026-05-21 | PRIMARY DOCUMENT | view · |
| 4 | 2026-05-12 | PRIMARY DOCUMENT | view · |
| 8-K | 2026-05-04 | 8-K | view · |
| 8-K | 2026-04-03 | 8-K | view · |
| 4 | 2026-04-02 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-23 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-23 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-23 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-23 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-23 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-23 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-23 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-23 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-23 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-23 | PRIMARY DOCUMENT | view · |
| 8-K | 2026-03-20 | 8-K | view · |
| 8-K | 2026-03-06 | 8-K | view · |
| 10-Q | 2026-03-03 | 10-Q | view · |
| 4 | 2026-03-03 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-03 | PRIMARY DOCUMENT | view · |
| 4 | 2026-03-03 | PRIMARY DOCUMENT | view · |
| 8-K | 2026-02-25 | 8-K | view · |
| DEF 14A | 2026-02-06 | DEF 14A | view · |
| 10-K | 2025-12-22 | 10-K | view · |
| 4 | 2025-12-03 | PRIMARY DOCUMENT | view · |
| 4 | 2025-12-01 | PRIMARY DOCUMENT | view · |
| 4 | 2025-12-01 | PRIMARY DOCUMENT | view · |
| 4 | 2025-12-01 | PRIMARY DOCUMENT | view · |
| 4 | 2025-12-01 | PRIMARY DOCUMENT | view · |
| 4 | 2025-12-01 | PRIMARY DOCUMENT | view · |
| 4 | 2025-12-01 | PRIMARY DOCUMENT | view · |
| 4 | 2025-12-01 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-25 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-25 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-25 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-25 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-25 | PRIMARY DOCUMENT | view · |
| 8-K | 2025-11-24 | 8-K | view · |
| 4 | 2025-11-20 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-20 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-20 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-20 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-20 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-20 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-20 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-20 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-20 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-18 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-18 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-18 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-18 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-18 | PRIMARY DOCUMENT | view · |
| 4 | 2025-11-14 | PRIMARY DOCUMENT | view · |
| 8-K | 2025-10-27 | 8-K | view · |
About A
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab l…
Options picks · A
ITM + OTM ideas from the latest scanLoading…
Congress trades · A
STOCK Act disclosuresLoading…
SEC filings & insiders · A
EDGAR · liveLoading…
Holders · A
Institutions & insider activityLoading…